[Skip to Content]
[Skip to Content Landing]
Views 110
Citations 0
Comment & Response
August 2017

Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer

Author Affiliations
  • 1Neurological Diseases Center, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, PR China
JAMA Oncol. 2017;3(8):1140-1141. doi:10.1001/jamaoncol.2017.2071

To the Editor In the March issue of JAMA Oncology, Melisko and colleagues1 published their randomized trial. We are concerned that their registration was delayed and their article is an example of selective outcome reporting.2

First, the investigation was initiated in October 2007 but registered with ClinicalTrials.gov 8 months later (June 2008).